ADAM12 and hepatocellular carcinoma: As an actor of TGF-β and Notch [8] signaling pathways, which are both involved in EMT, ADAM12 might enhance EMT by synergizing these pathways, although such a mechanism has not yet been addressed in the context of HCC progression.